Cipla Q4 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,357.00
26.15 (1.96%)
26.15 (1.96%)Volume22.93 K
Updated: Mon 16 Feb, 2026 | 15:29:46
NSE
1,356.4024.90 (1.87%)
24.90 (1.87%)Volume1.62 M
Updated: Mon 16 Feb, 2026 | 15:51:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Cipla Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,500.83 | 6,373.68 | 2.55% | 5,135.72 | 7.11% |
| Depreciation/ Amortization | 308.73 | 278.35 | 10.34% | 288.34 | 7.07% |
| Operating Income | 1,228.86 | 700.80 | -28.10% | 1,027.52 | 19.59% |
| Net Income | 1,221.84 | 675.80 | -22.20% | 939.04 | 30.12% |
| Other Operating Expenses Total | 1,769.98 | 1,862.36 | 9.10% | 1,713.03 | 3.32% |
| Net Income Before Taxes | 1,504.30 | 893.11 | -21.49% | 1,259.26 | 19.46% |
| Total Revenue | 6,729.69 | 7,074.48 | -4.85% | 6,163.24 | 9.19% |
| Selling/ General/ Admin Expenses Total | 1,233.10 | 1,324.98 | 2.96% | 1,084.23 | 13.73% |
| Diluted Normalized EPS | 15.12 | 10.94 | -22.19% | 11.63 | 29.95% |